Search Results
How the treatment of DLBCL and FL are changing in the UK
New data on DLBCL in the UK and its impact on treatment decisions
How the treatment landscape of DLBCL is changing: R-CHOP vs pola-R-CHP
First- and second-line treatment in DLBCL
Applying molecular understanding of DLBCL to management strategies
Dr Matthew Wilson - Update on and management of diffuse large B-cell lymphoma
An insight into how bispecifics are changing the lymphoma treatment landscape
Predictors of outcome for follicular lymphoma
Updates in the DLBCL treatment landscape
DLBCL Treatment Approaches: What You Need to Know
The need for more effective, less toxic therapies in frontline DLBCL treatment
Investigating Epcoritamab for Follicular Lymphoma and Beyond With Reid Merryman, MD